These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26285192)

  • 1. The impact of policies to reduce blood glucose test strip utilization and costs in Canada.
    Gomes T; Martins D; Cheng L; Kratzer J; Juurlink DN; Shah BR; Mamdani MM; Paterson JM; Law MR
    Can J Public Health; 2015 Apr; 106(4):e210-6. PubMed ID: 26285192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-Monitoring of Blood Glucose Levels: Evaluating the Impact of a Policy of Quantity Limits on Test-Strip Use and Costs.
    Gomes T; Martins D; Tadrous M; Paterson JM; Shah BR; Juurlink DN; Singh S; Mamdani MM
    Can J Diabetes; 2016 Oct; 40(5):431-435. PubMed ID: 27212047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-Monitoring of Blood Glucose: Impact of Quantity Limits in Public Drug Formularies on Provincial Costs Across Canada.
    Knowles SR; Lee K; Paterson JM; Shah BR; Mamdani MM; Juurlink DN; Gomes T
    Can J Diabetes; 2017 Apr; 41(2):138-142. PubMed ID: 27989494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Blood Glucose Test Strips Reimbursement Limits on Utilization, Costs, and Health-care Utilization in British Columbia.
    Itiola AJ; Cheng L; Zhang W; Gomes T; Shah BR; Law MR
    Can J Diabetes; 2024 Feb; 48(1):10-17.e5. PubMed ID: 37611660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunity Cost and Policy: A Utilization Review of Self-monitoring of Blood Glucose in Manitoba, Canada.
    Serwylo O; Friesen K; Falk J; Bugden S
    Clin Ther; 2016 Apr; 38(4):929-35. PubMed ID: 26947797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of a Blood Glucose Test Strip Quantity-Limit Policy With Patient Outcomes: A Population-Based Study.
    Gomes T; Martins D; Tadrous M; Paterson JM; Shah BR; Tu JV; Juurlink DN; Chu A; Mamdani MM
    JAMA Intern Med; 2017 Jan; 177(1):61-66. PubMed ID: 27820619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood glucose test strips: options to reduce usage.
    Gomes T; Juurlink DN; Shah BR; Paterson JM; Mamdani MM
    CMAJ; 2010 Jan; 182(1):35-8. PubMed ID: 20026624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns, Policy and Appropriateness: A 12-Year Utilization Review of Blood Glucose Test Strip Use in Insulin Users.
    Falk J; Friesen KJ; Okunnu A; Bugden S
    Can J Diabetes; 2017 Aug; 41(4):385-391. PubMed ID: 28410881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational use of blood glucose test strips for self-monitoring in patients with diabetes mellitus: Economic impact in the Portuguese healthcare system.
    Risso T; Furtado C
    Diabetes Res Clin Pract; 2017 Dec; 134():161-167. PubMed ID: 28951334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in self-monitored, blood glucose test strip utilization by therapy for type 2 diabetes mellitus.
    Tavares R; Duclos M; Brabant MJ; Checchin D; Bosnic N; Turvey K; Terres JA
    Acta Diabetol; 2016 Jun; 53(3):483-92. PubMed ID: 26972690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between type of drug therapy and blood glucose self-monitoring test strips claimed by beneficiaries of the Seniors' Pharmacare Program in Nova Scotia, Canada.
    Sanyal C; Graham SD; Cooke C; Sketris I; Frail DM; Flowerdew G
    BMC Health Serv Res; 2008 May; 8():111. PubMed ID: 18501012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in Blood Glucose Test Strip Utilization: A Population-Wide Analysis in Saskatchewan, Canada.
    Kosar L; Alsabbagh W; Lu X; Lix LM; Shevchuk Y; Teare GF; Champagne A; Blackburn DF
    Can J Diabetes; 2018 Feb; 42(1):5-10. PubMed ID: 28499790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Projected impact of biosimilar substitution policies on drug use and costs in Ontario, Canada: a cross-sectional time series analysis.
    Gomes T; McCormack D; Kitchen SA; Paterson JM; Mamdani MM; Proulx L; Bayliss L; Tadrous M
    CMAJ Open; 2021; 9(4):E1055-E1062. PubMed ID: 34815261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Net health plan savings from reference pricing for angiotensin-converting enzyme inhibitors in elderly British Columbia residents.
    Schneeweiss S; Dormuth C; Grootendorst P; Soumerai SB; Maclure M
    Med Care; 2004 Jul; 42(7):653-60. PubMed ID: 15213490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of coxib formulary restrictions on analgesic use and cost: regional evidence from Canada.
    Marshall DA; Willison DJ; Grootendorst P; LeLorier J; Maclure M; Kulin NA; Sheehy OE; Warren L; Sykora K; Rahme E
    Health Policy; 2007 Nov; 84(1):1-13. PubMed ID: 17570558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cost-sharing changes on self-monitoring of blood glucose.
    Karter AJ; Parker MM; Moffet HH; Ahmed AT; Chan J; Spence MM; Selby JV; Ettner SL
    Am J Manag Care; 2007 Jul; 13(7):408-16. PubMed ID: 17620036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flash Glucose Monitoring System for People with Type 1 or Type 2 Diabetes: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2019; 19(8):1-108. PubMed ID: 31942227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoting health and reducing costs: a role for reform of self-monitoring of blood glucose provision within the National Health Service.
    Leigh S; Idris I; Collins B; Granby P; Noble M; Parker M
    Diabet Med; 2016 May; 33(5):681-90. PubMed ID: 26443548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost of self-monitoring of blood glucose in the United States among patients on an insulin regimen for diabetes.
    Yeaw J; Lee WC; Aagren M; Christensen T
    J Manag Care Pharm; 2012; 18(1):21-32. PubMed ID: 22235952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations in costs and use of provincially-funded testosterone replacement therapy across Canada: a population-based study.
    Tadrous M; Martins D; Lee K; Knowles S; Mamdani MM; Juurlink DN; Gomes T
    Expert Rev Pharmacoecon Outcomes Res; 2016 Dec; 16(6):803-807. PubMed ID: 26986676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.